RaloxifeneHerceptinCalcificationsTripleNegativeBreastCancerGermlineMutationAdjuvantTherapyBreastTomosynthesisGuaranteedRenewableInsuranceImmunotherapyGeneticPredispositionHormoneReplacementTherapyFISHCytostaticAngiogenesisDown-StagingHormoneReceptorStatusDimplingAdvocacyGenomicTestingCystCheckpointInhibitorCMFChemotherapySERM5-FluorouracilPalpationNodePositiveMultifocalTumorsAbsoluteRiskAyurvedaMultimodalityTherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55OvarianSuppressionOligometastasesBevacizumabPARPInhibitorsBI-RADSLymphNodeStatusEstrogenFlowCytometryPathologicResponseBilateralProphylacticMastectomyTyrosine-KinaseInhibitorWomen ages40+ shouldhave a clinicalbreast examat least yearlyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCytotoxicAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancer1 in 8womenBOCABRCAGeneMegestrolAcetateEGFR(epidermalgrowth factorreceptor)RADTumorGradeIntraductalPapillomaAxillarySamplingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Women ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DoseDenseTherapyRadiotherapyLCISEstradiolBiopsyAntibodyTherapyFamilyHistoryACChemotherapyPhysicalactivity mayreduce therisk of breastcancersMetastasisECOGScoreNeoadjuvantTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriplePositiveBreastCancerCo-survivorMorpheaChemotherapyStagingTamoxifenAnastrozoleMastodyniaGeneMutationPalbociclibEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearProgestinPI3KinaseInhibitorsSelf-examinationER+CyclophosphamideLymphoscintigraphyNeoplasmRelapseKi-67RateBrachytherapyLumpectomyMastectomyCachexiamTORInhibitorsDoxorubicinAntiemeticApoptosisMRIIn-situCarcinomaHER-2CDK4/6InhibitorsPrecisionMedicinePaclitaxelLumpDefinitiveSurgeryAromataseInhibitorsLapatinibPhyllodesTumorExcisionalBiopsyInvasiveBreastCancerKappaEpsilonER-GeneticCounselingChemopreventionPagetDiseaseMethotrexateDocetaxelAdenocarcinomaCapecitabineNodeNegativeGailModelBreastCancerFibroadenomaCAMAlopeciaRaloxifeneHerceptinCalcificationsTripleNegativeBreastCancerGermlineMutationAdjuvantTherapyBreastTomosynthesisGuaranteedRenewableInsuranceImmunotherapyGeneticPredispositionHormoneReplacementTherapyFISHCytostaticAngiogenesisDown-StagingHormoneReceptorStatusDimplingAdvocacyGenomicTestingCystCheckpointInhibitorCMFChemotherapySERM5-FluorouracilPalpationNodePositiveMultifocalTumorsAbsoluteRiskAyurvedaMultimodalityTherapyBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55OvarianSuppressionOligometastasesBevacizumabPARPInhibitorsBI-RADSLymphNodeStatusEstrogenFlowCytometryPathologicResponseBilateralProphylacticMastectomyTyrosine-KinaseInhibitorWomen ages40+ shouldhave a clinicalbreast examat least yearlyMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltCytotoxicAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancer1 in 8womenBOCABRCAGeneMegestrolAcetateEGFR(epidermalgrowth factorreceptor)RADTumorGradeIntraductalPapillomaAxillarySamplingFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.Women ages20-39 yoshould have aclinical breastexam at leastevery 3 years.DoseDenseTherapyRadiotherapyLCISEstradiolBiopsyAntibodyTherapyFamilyHistoryACChemotherapyPhysicalactivity mayreduce therisk of breastcancersMetastasisECOGScoreNeoadjuvantTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenTriplePositiveBreastCancerCo-survivorMorpheaChemotherapyStagingTamoxifenAnastrozoleMastodyniaGeneMutationPalbociclibEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearProgestinPI3KinaseInhibitorsSelf-examinationER+CyclophosphamideLymphoscintigraphyNeoplasmRelapseKi-67RateBrachytherapyLumpectomyMastectomyCachexiamTORInhibitorsDoxorubicinAntiemeticApoptosisMRIIn-situCarcinomaHER-2CDK4/6InhibitorsPrecisionMedicinePaclitaxelLumpDefinitiveSurgeryAromataseInhibitorsLapatinibPhyllodesTumorExcisionalBiopsyInvasiveBreastCancerKappaEpsilonER-GeneticCounselingChemopreventionPagetDiseaseMethotrexateDocetaxelAdenocarcinomaCapecitabineNodeNegativeGailModelBreastCancerFibroadenomaCAMAlopecia

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Raloxifene
  2. Herceptin
  3. Calcifications
  4. Triple Negative Breast Cancer
  5. Germline Mutation
  6. Adjuvant Therapy
  7. Breast Tomosynthesis
  8. Guaranteed Renewable Insurance
  9. Immunotherapy
  10. Genetic Predisposition
  11. Hormone Replacement Therapy
  12. FISH
  13. Cytostatic
  14. Angiogenesis
  15. Down-Staging
  16. Hormone Receptor Status
  17. Dimpling
  18. Advocacy
  19. Genomic Testing
  20. Cyst
  21. Checkpoint Inhibitor
  22. CMF Chemotherapy
  23. SERM
  24. 5-Fluorouracil
  25. Palpation
  26. Node Positive
  27. Multifocal Tumors
  28. Absolute Risk
  29. Ayurveda
  30. Multimodality Therapy
  31. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  32. Ovarian Suppression
  33. Oligometastases
  34. Bevacizumab
  35. PARP Inhibitors
  36. BI-RADS
  37. Lymph Node Status
  38. Estrogen
  39. Flow Cytometry
  40. Pathologic Response
  41. Bilateral Prophylactic Mastectomy
  42. Tyrosine-Kinase Inhibitor
  43. Women ages 40+ should have a clinical breast exam at least yearly
  44. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  45. Cytotoxic
  46. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  47. 1 in 8 women
  48. BOCA
  49. BRCA Gene
  50. Megestrol Acetate
  51. EGFR (epidermal growth factor receptor)
  52. RAD
  53. Tumor Grade
  54. Intraductal Papilloma
  55. Axillary Sampling
  56. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  57. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  58. Dose Dense Therapy
  59. Radiotherapy
  60. LCIS
  61. Estradiol
  62. Biopsy
  63. Antibody Therapy
  64. Family History
  65. AC Chemotherapy
  66. Physical activity may reduce the risk of breast cancers
  67. Metastasis
  68. ECOG Score
  69. Neoadjuvant Therapy
  70. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  71. Triple Positive Breast Cancer
  72. Co-survivor
  73. Morphea
  74. Chemotherapy
  75. Staging
  76. Tamoxifen
  77. Anastrozole
  78. Mastodynia
  79. Gene Mutation
  80. Palbociclib
  81. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  82. Progestin
  83. PI3 Kinase Inhibitors
  84. Self-examination
  85. ER+
  86. Cyclophosphamide
  87. Lymphoscintigraphy
  88. Neoplasm
  89. Relapse
  90. Ki-67 Rate
  91. Brachytherapy
  92. Lumpectomy
  93. Mastectomy
  94. Cachexia
  95. mTOR Inhibitors
  96. Doxorubicin
  97. Antiemetic
  98. Apoptosis
  99. MRI
  100. In-situ Carcinoma
  101. HER-2
  102. CDK4/6 Inhibitors
  103. Precision Medicine
  104. Paclitaxel
  105. Lump
  106. Definitive Surgery
  107. Aromatase Inhibitors
  108. Lapatinib
  109. Phyllodes Tumor
  110. Excisional Biopsy
  111. Invasive Breast Cancer
  112. Kappa Epsilon
  113. ER-
  114. Genetic Counseling
  115. Chemoprevention
  116. Paget Disease
  117. Methotrexate
  118. Docetaxel
  119. Adenocarcinoma
  120. Capecitabine
  121. Node Negative
  122. Gail Model
  123. Breast Cancer
  124. Fibroadenoma
  125. CAM
  126. Alopecia